PPARG and type 2 diabetes mellitus: Enhancing insulin sensitivity via targeting PPARγ and β-catenin is one of the attractive pathways for the treatment of T2DM; therefore, Mourad et al. synthesized analogs of α-phthalimido-o-toluoyl2-aminothiazole hybrids and carried out the anti-diabetic activity.